Microbot Medical Inc. 8-K

What Happened
Microbot Medical Inc. announced on April 14, 2026 (via a press release furnished as Exhibit 99.1) that it will highlight recent commercial achievements leading to the Full Market Release (FMR) of its LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference (April 13–16, 2026). CEO, President & Chairman Harel Gadot will present live at 10:15 a.m. ET on Wednesday, April 15, 2026. The presentation will be webcast and accessible from the company’s Investors section at https://ir.microbotmedical.com/.

Key Details

• Press release issued April 14, 2026 and furnished as Exhibit 99.1 to the Form 8-K.
• Needham Virtual Healthcare Conference dates: April 13–16, 2026; Microbot presentation: April 15, 2026 at 10:15 a.m. ET.
• Topic: commercial achievements and the recent Full Market Release (FMR) of the LIBERTY Endovascular Robotic System.
• Management will address strategic positioning, growth opportunities, and market needs including physician radiation risks, physical strain and staffing issues; presentation will be webcast.

Why It Matters
This disclosure signals Microbot’s move from development toward broader commercialization by announcing the LIBERTY system’s Full Market Release and promoting the product to analysts and investors at a major healthcare conference. The live CEO presentation and webcast increase public visibility and provide a forum for management to discuss commercialization progress and market opportunity. The filing does not include new financial results or executive changes—it's a Regulation FD disclosure to broadly share corporate updates and the webcast details.